Negotiating Collaborative Healthcare Research Agreements
Structuring Joint Obligations, IP Rights, Confidentiality and Other Key Provisions
Recording of a 90-minute CLE webinar with Q&A
This CLE webinar will review key provisions in collaborative research agreements, outline best practices for structuring effective provisions and agreements, and provide guidance for healthcare counsel on handling the potential challenges in negotiations.
- Potential obstacles in collaborative research agreement negotiations
- Key provisions and the critical issues surrounding them
- Structure and governance
- Joint obligations
- IP issues
- Publication and other use
- Other key terms
- Best practices for effectively crafting collaborative research agreements
The panel will review these and other key issues:
- What are the significant stumbling blocks that can hinder the parties in negotiating a collaborative research agreement?
- What collaborative research agreement provisions ensure that parties’ rights regarding any intellectual property created as a result of the research are protected?
- What challenges are raised by multiple licenses and how can counsel overcome those challenges?
Eve M. Brunts
Ropes & Gray
Ms. Brunts assists a diverse array of healthcare clients with reimbursement, clinical research, regulatory and... | Read More
Ms. Brunts assists a diverse array of healthcare clients with reimbursement, clinical research, regulatory and compliance matters. She regularly advises healthcare providers, pharmaceutical and medical device manufacturers, and managed care organizations on issues such as Medicare and Medicaid coverage, claims and payment requirements for a variety of services; government regulation and funding of clinical research; reimbursement for healthcare services in clinical trials; managed care contracting; federal and state fraud and abuse laws; and federal and state laws regulating manufacturer interactions with providers.Close
Susan M. Galli
Ropes & Gray
Ms. Galli focuses her practice on advising pharmaceutical, biotech, medical device and other... | Read More
Ms. Galli focuses her practice on advising pharmaceutical, biotech, medical device and other technology companies on licensing, collaboration and research agreements, joint ventures, and other major transactions. She also advises research institutions on developing vehicles for translational research and on structuring transactions with industry, the government and other institutions. Ms. Galli has been a faculty member for CLE programs on numerous licensing and research topics and she served on a Massachusetts Biotechnology Council committee focusing on transactions between industry and research institutions.Close
Julie Rusczek, Esq.
Health Sciences Law Group
Ms. Rusczek focuses her practice on research compliance issues, representing institutions, pharmaceutical and device... | Read More
Ms. Rusczek focuses her practice on research compliance issues, representing institutions, pharmaceutical and device companies, and other entities on matters such as developing research review policies, ensuring adequate protections for human research subjects, reviewing contracts for various research arrangements, and providing advice regarding compliance with privacy laws. She also represents hospitals, health systems and long-term care providers on a wide range of health law issues including medical staff matters, informed consent, patient confidentiality, reimbursement, and fraud and abuse.Close